KalGene is a biotechnology company developing precision medicine therapeutics designed to slow the progression of Alzheimer’s disease with an antibody-based approach. For more information visit: www.kalgene.com.
Location: Canada, Ontario, Kingston
Employees: 51-200
Founded date: 2007
Investors 4
| Date | Name | Website |
| - | adMare Bio... | admarebio.... |
| - | Lumira Ven... | lumiravent... |
| - | K2X | k2x.capita... |
| - | Anges Québ... | angesquebe... |
Mentions in press and media 1
| Date | Title | Description |
| 27.11.2017 | KalGene Pharmaceuticals Closes Series A Financing | KalGene Pharmaceuticals, Inc., a Montreal and Toronto, Canada-based pre-clinical stage company, closed a Series A financing of undisclosed amount. The round was was led by Lumira Capital with participation from Anges Québec, Anges Québec Ca... |